Scaffold Technology Comprehensive Study by Type (Hydrogels, Polymeric Scaffolds, Nanofiber Based Scaffolds, Micropatterned Surface Microplates), Application (Cancer Cell Research, Stem Cell Research, Regenerative Medicine, Tissue Engineering, Microfluidics, Cell-based assays, Others), End users (Cell attachment and migration, Nutrients and products diffusion, Cell phase behavior modification, Others), Technology (Decellularized technology, Synthetic Scaffold, 3D printing, Others) Players and Region - Global Market Outlook to 2026

Scaffold Technology Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Scaffold Technology Market Scope?
According to the WHO, Cancer is the second leading cause of death with 9.6 million deaths in 2018. Scaffold technology is a branch of tissue engineering that performs 3D cell cultural assays, overcoming limitations executed upon by 2D Cell culture for various drug delivery and development process. It is primarily tissue engineering, evolving into biological alternatives, with applications for replacing, regenerating and repairing diseased or defective organs or tissues. Further, increasing preference for the regenerative technology, and rising prevalence of organ transplant for the treatment the damaged organ or tissues are few factors driving the global scaffold technology market

The Scaffold Technology market study is being classified by Type (Hydrogels, Polymeric Scaffolds, Nanofiber Based Scaffolds and Micropatterned Surface Microplates), by Application (Cancer Cell Research, Stem Cell Research, Regenerative Medicine, Tissue Engineering, Microfluidics, Cell-based assays and Others) and major geographies with country level break-up.

The global scaffold technology market is fragmented with top regional and international market players. Key players are developing innovative stem cell substrates and helping out with regenerative medicines and organogenesis modeling supporting growth of the scaffold technology market. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Scaffold Technology market throughout the predicted period.

Koninklijke DSM N.V. (Netherlands), Thermo Fisher Scientific, Inc. (United States), Arterial Remodeling Technologies S.A (France), Spine Smith, LP (United States), Orthocell Ltd. (Australia), Invivo Therapeutics Holdings Corporation (United States), Lifenet Inc. (United States), Biostage, Inc. (United States), Arsenal Medical Inc. (United States), Organogenesis, Inc. (United States) and Tissue Regenix Group Plc. ((United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are 3D Biotek LLC (United States), Molecular Matrix, Inc. (United States), ReproCELL Europe Ltd (Reinnervate) (United Kingdom) and Pelo Biotech GmbH (Germany).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Scaffold Technology market by Type, Application and Region.

On the basis of geography, the market of Scaffold Technology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

March 2019, Researchers from Nagasaki University and Saga University have collaborated to create scaffold-free esophageal structures with 3D bioprinting. The findings of the research were published in the paper titled, Regeneration of esophagus using a scaffold-free biomimetic structure created with biothree-dimensional printing. The results shows that “the esophagus-like scaffold-free tubular structures created using bio-3D printing could hold promise as a substitute for the repair of esophageal defects.”
March 2018, InVivo Therapeutics Holdings Corp. (NVIV) has received supplemental Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) for a second pivotal clinical study of the company’s Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). The 20-patient randomized, controlled trial is designed to enhance the existing clinical evidence for the Neuro-Spinal Scaffold from the company’s single-arm INSPIRE study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury).

Influencing Market Trend
  • 3D Printing Technology in the Scaffold Manufacturing Process

Market Drivers
  • Growing Demand for Organ Transplantation
  • Surging Number of Patients Suffering from Cancer Requiring Organ Transplant
  • Increasing Application of Scaffolds for the Replacement and Regeneration of Defective Organs

Opportunities
  • High Investment and R & D in the Tissue Engineering Sector

Restraints
  • Failures Associated with 3D Cell Culture Model May hamper the Market Growth

Challenges
  • High Cost Involved in Scaffold Technology for its Research Activities


Key Target Audience
Scaffold Technology Service Providers, Research Organizations, Industry Associations, Potential Investors, Government and Regulatory Bodies and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Hydrogels
  • Polymeric Scaffolds
  • Nanofiber Based Scaffolds
  • Micropatterned Surface Microplates
By Application
  • Cancer Cell Research
  • Stem Cell Research
  • Regenerative Medicine
  • Tissue Engineering
  • Microfluidics
  • Cell-based assays
  • Others
By End users
  • Cell attachment and migration
  • Nutrients and products diffusion
  • Cell phase behavior modification
  • Others

By Technology
  • Decellularized technology
  • Synthetic Scaffold
  • 3D printing
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Organ Transplantation
      • 3.2.2. Surging Number of Patients Suffering from Cancer Requiring Organ Transplant
      • 3.2.3. Increasing Application of Scaffolds for the Replacement and Regeneration of Defective Organs
    • 3.3. Market Challenges
      • 3.3.1. High Cost Involved in Scaffold Technology for its Research Activities
    • 3.4. Market Trends
      • 3.4.1. 3D Printing Technology in the Scaffold Manufacturing Process
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Scaffold Technology, by Type, Application, End users, Technology and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Scaffold Technology (Value)
      • 5.2.1. Global Scaffold Technology by: Type (Value)
        • 5.2.1.1. Hydrogels
        • 5.2.1.2. Polymeric Scaffolds
        • 5.2.1.3. Nanofiber Based Scaffolds
        • 5.2.1.4. Micropatterned Surface Microplates
      • 5.2.2. Global Scaffold Technology by: Application (Value)
        • 5.2.2.1. Cancer Cell Research
        • 5.2.2.2. Stem Cell Research
        • 5.2.2.3. Regenerative Medicine
        • 5.2.2.4. Tissue Engineering
        • 5.2.2.5. Microfluidics
        • 5.2.2.6. Cell-based assays
        • 5.2.2.7. Others
      • 5.2.3. Global Scaffold Technology by: End users (Value)
        • 5.2.3.1. Cell attachment and migration
        • 5.2.3.2. Nutrients and products diffusion
        • 5.2.3.3. Cell phase behavior modification
        • 5.2.3.4. Others
      • 5.2.4. Global Scaffold Technology by: Technology (Value)
        • 5.2.4.1. Decellularized technology
        • 5.2.4.2. Synthetic Scaffold
        • 5.2.4.3. 3D printing
        • 5.2.4.4. Others
      • 5.2.5. Global Scaffold Technology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Scaffold Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Koninklijke DSM N.V. (Netherlands)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Arterial Remodeling Technologies S.A (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Spine Smith, LP (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Orthocell Ltd. (Australia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Invivo Therapeutics Holdings Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lifenet Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biostage, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Arsenal Medical Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Organogenesis, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Tissue Regenix Group Plc. ((United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Scaffold Technology Sale, by Type, Application, End users, Technology and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Scaffold Technology (Value)
      • 7.2.1. Global Scaffold Technology by: Type (Value)
        • 7.2.1.1. Hydrogels
        • 7.2.1.2. Polymeric Scaffolds
        • 7.2.1.3. Nanofiber Based Scaffolds
        • 7.2.1.4. Micropatterned Surface Microplates
      • 7.2.2. Global Scaffold Technology by: Application (Value)
        • 7.2.2.1. Cancer Cell Research
        • 7.2.2.2. Stem Cell Research
        • 7.2.2.3. Regenerative Medicine
        • 7.2.2.4. Tissue Engineering
        • 7.2.2.5. Microfluidics
        • 7.2.2.6. Cell-based assays
        • 7.2.2.7. Others
      • 7.2.3. Global Scaffold Technology by: End users (Value)
        • 7.2.3.1. Cell attachment and migration
        • 7.2.3.2. Nutrients and products diffusion
        • 7.2.3.3. Cell phase behavior modification
        • 7.2.3.4. Others
      • 7.2.4. Global Scaffold Technology by: Technology (Value)
        • 7.2.4.1. Decellularized technology
        • 7.2.4.2. Synthetic Scaffold
        • 7.2.4.3. 3D printing
        • 7.2.4.4. Others
      • 7.2.5. Global Scaffold Technology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Scaffold Technology: by Type(USD Million)
  • Table 2. Scaffold Technology Hydrogels , by Region USD Million (2015-2020)
  • Table 3. Scaffold Technology Polymeric Scaffolds , by Region USD Million (2015-2020)
  • Table 4. Scaffold Technology Nanofiber Based Scaffolds , by Region USD Million (2015-2020)
  • Table 5. Scaffold Technology Micropatterned Surface Microplates , by Region USD Million (2015-2020)
  • Table 6. Scaffold Technology: by Application(USD Million)
  • Table 7. Scaffold Technology Cancer Cell Research , by Region USD Million (2015-2020)
  • Table 8. Scaffold Technology Stem Cell Research , by Region USD Million (2015-2020)
  • Table 9. Scaffold Technology Regenerative Medicine , by Region USD Million (2015-2020)
  • Table 10. Scaffold Technology Tissue Engineering , by Region USD Million (2015-2020)
  • Table 11. Scaffold Technology Microfluidics , by Region USD Million (2015-2020)
  • Table 12. Scaffold Technology Cell-based assays , by Region USD Million (2015-2020)
  • Table 13. Scaffold Technology Others , by Region USD Million (2015-2020)
  • Table 14. Scaffold Technology: by End users(USD Million)
  • Table 15. Scaffold Technology Cell attachment and migration , by Region USD Million (2015-2020)
  • Table 16. Scaffold Technology Nutrients and products diffusion , by Region USD Million (2015-2020)
  • Table 17. Scaffold Technology Cell phase behavior modification , by Region USD Million (2015-2020)
  • Table 18. Scaffold Technology Others , by Region USD Million (2015-2020)
  • Table 19. Scaffold Technology: by Technology(USD Million)
  • Table 20. Scaffold Technology Decellularized technology , by Region USD Million (2015-2020)
  • Table 21. Scaffold Technology Synthetic Scaffold , by Region USD Million (2015-2020)
  • Table 22. Scaffold Technology 3D printing , by Region USD Million (2015-2020)
  • Table 23. Scaffold Technology Others , by Region USD Million (2015-2020)
  • Table 24. South America Scaffold Technology, by Country USD Million (2015-2020)
  • Table 25. South America Scaffold Technology, by Type USD Million (2015-2020)
  • Table 26. South America Scaffold Technology, by Application USD Million (2015-2020)
  • Table 27. South America Scaffold Technology, by End users USD Million (2015-2020)
  • Table 28. South America Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 29. Brazil Scaffold Technology, by Type USD Million (2015-2020)
  • Table 30. Brazil Scaffold Technology, by Application USD Million (2015-2020)
  • Table 31. Brazil Scaffold Technology, by End users USD Million (2015-2020)
  • Table 32. Brazil Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 33. Argentina Scaffold Technology, by Type USD Million (2015-2020)
  • Table 34. Argentina Scaffold Technology, by Application USD Million (2015-2020)
  • Table 35. Argentina Scaffold Technology, by End users USD Million (2015-2020)
  • Table 36. Argentina Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 37. Rest of South America Scaffold Technology, by Type USD Million (2015-2020)
  • Table 38. Rest of South America Scaffold Technology, by Application USD Million (2015-2020)
  • Table 39. Rest of South America Scaffold Technology, by End users USD Million (2015-2020)
  • Table 40. Rest of South America Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 41. Asia Pacific Scaffold Technology, by Country USD Million (2015-2020)
  • Table 42. Asia Pacific Scaffold Technology, by Type USD Million (2015-2020)
  • Table 43. Asia Pacific Scaffold Technology, by Application USD Million (2015-2020)
  • Table 44. Asia Pacific Scaffold Technology, by End users USD Million (2015-2020)
  • Table 45. Asia Pacific Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 46. China Scaffold Technology, by Type USD Million (2015-2020)
  • Table 47. China Scaffold Technology, by Application USD Million (2015-2020)
  • Table 48. China Scaffold Technology, by End users USD Million (2015-2020)
  • Table 49. China Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 50. Japan Scaffold Technology, by Type USD Million (2015-2020)
  • Table 51. Japan Scaffold Technology, by Application USD Million (2015-2020)
  • Table 52. Japan Scaffold Technology, by End users USD Million (2015-2020)
  • Table 53. Japan Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 54. India Scaffold Technology, by Type USD Million (2015-2020)
  • Table 55. India Scaffold Technology, by Application USD Million (2015-2020)
  • Table 56. India Scaffold Technology, by End users USD Million (2015-2020)
  • Table 57. India Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 58. South Korea Scaffold Technology, by Type USD Million (2015-2020)
  • Table 59. South Korea Scaffold Technology, by Application USD Million (2015-2020)
  • Table 60. South Korea Scaffold Technology, by End users USD Million (2015-2020)
  • Table 61. South Korea Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 62. Taiwan Scaffold Technology, by Type USD Million (2015-2020)
  • Table 63. Taiwan Scaffold Technology, by Application USD Million (2015-2020)
  • Table 64. Taiwan Scaffold Technology, by End users USD Million (2015-2020)
  • Table 65. Taiwan Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 66. Australia Scaffold Technology, by Type USD Million (2015-2020)
  • Table 67. Australia Scaffold Technology, by Application USD Million (2015-2020)
  • Table 68. Australia Scaffold Technology, by End users USD Million (2015-2020)
  • Table 69. Australia Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Scaffold Technology, by Type USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Scaffold Technology, by Application USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Scaffold Technology, by End users USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 74. Europe Scaffold Technology, by Country USD Million (2015-2020)
  • Table 75. Europe Scaffold Technology, by Type USD Million (2015-2020)
  • Table 76. Europe Scaffold Technology, by Application USD Million (2015-2020)
  • Table 77. Europe Scaffold Technology, by End users USD Million (2015-2020)
  • Table 78. Europe Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 79. Germany Scaffold Technology, by Type USD Million (2015-2020)
  • Table 80. Germany Scaffold Technology, by Application USD Million (2015-2020)
  • Table 81. Germany Scaffold Technology, by End users USD Million (2015-2020)
  • Table 82. Germany Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 83. France Scaffold Technology, by Type USD Million (2015-2020)
  • Table 84. France Scaffold Technology, by Application USD Million (2015-2020)
  • Table 85. France Scaffold Technology, by End users USD Million (2015-2020)
  • Table 86. France Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 87. Italy Scaffold Technology, by Type USD Million (2015-2020)
  • Table 88. Italy Scaffold Technology, by Application USD Million (2015-2020)
  • Table 89. Italy Scaffold Technology, by End users USD Million (2015-2020)
  • Table 90. Italy Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 91. United Kingdom Scaffold Technology, by Type USD Million (2015-2020)
  • Table 92. United Kingdom Scaffold Technology, by Application USD Million (2015-2020)
  • Table 93. United Kingdom Scaffold Technology, by End users USD Million (2015-2020)
  • Table 94. United Kingdom Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 95. Netherlands Scaffold Technology, by Type USD Million (2015-2020)
  • Table 96. Netherlands Scaffold Technology, by Application USD Million (2015-2020)
  • Table 97. Netherlands Scaffold Technology, by End users USD Million (2015-2020)
  • Table 98. Netherlands Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 99. Rest of Europe Scaffold Technology, by Type USD Million (2015-2020)
  • Table 100. Rest of Europe Scaffold Technology, by Application USD Million (2015-2020)
  • Table 101. Rest of Europe Scaffold Technology, by End users USD Million (2015-2020)
  • Table 102. Rest of Europe Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 103. MEA Scaffold Technology, by Country USD Million (2015-2020)
  • Table 104. MEA Scaffold Technology, by Type USD Million (2015-2020)
  • Table 105. MEA Scaffold Technology, by Application USD Million (2015-2020)
  • Table 106. MEA Scaffold Technology, by End users USD Million (2015-2020)
  • Table 107. MEA Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 108. Middle East Scaffold Technology, by Type USD Million (2015-2020)
  • Table 109. Middle East Scaffold Technology, by Application USD Million (2015-2020)
  • Table 110. Middle East Scaffold Technology, by End users USD Million (2015-2020)
  • Table 111. Middle East Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 112. Africa Scaffold Technology, by Type USD Million (2015-2020)
  • Table 113. Africa Scaffold Technology, by Application USD Million (2015-2020)
  • Table 114. Africa Scaffold Technology, by End users USD Million (2015-2020)
  • Table 115. Africa Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 116. North America Scaffold Technology, by Country USD Million (2015-2020)
  • Table 117. North America Scaffold Technology, by Type USD Million (2015-2020)
  • Table 118. North America Scaffold Technology, by Application USD Million (2015-2020)
  • Table 119. North America Scaffold Technology, by End users USD Million (2015-2020)
  • Table 120. North America Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 121. United States Scaffold Technology, by Type USD Million (2015-2020)
  • Table 122. United States Scaffold Technology, by Application USD Million (2015-2020)
  • Table 123. United States Scaffold Technology, by End users USD Million (2015-2020)
  • Table 124. United States Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 125. Canada Scaffold Technology, by Type USD Million (2015-2020)
  • Table 126. Canada Scaffold Technology, by Application USD Million (2015-2020)
  • Table 127. Canada Scaffold Technology, by End users USD Million (2015-2020)
  • Table 128. Canada Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 129. Mexico Scaffold Technology, by Type USD Million (2015-2020)
  • Table 130. Mexico Scaffold Technology, by Application USD Million (2015-2020)
  • Table 131. Mexico Scaffold Technology, by End users USD Million (2015-2020)
  • Table 132. Mexico Scaffold Technology, by Technology USD Million (2015-2020)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Scaffold Technology: by Type(USD Million)
  • Table 145. Scaffold Technology Hydrogels , by Region USD Million (2021-2026)
  • Table 146. Scaffold Technology Polymeric Scaffolds , by Region USD Million (2021-2026)
  • Table 147. Scaffold Technology Nanofiber Based Scaffolds , by Region USD Million (2021-2026)
  • Table 148. Scaffold Technology Micropatterned Surface Microplates , by Region USD Million (2021-2026)
  • Table 149. Scaffold Technology: by Application(USD Million)
  • Table 150. Scaffold Technology Cancer Cell Research , by Region USD Million (2021-2026)
  • Table 151. Scaffold Technology Stem Cell Research , by Region USD Million (2021-2026)
  • Table 152. Scaffold Technology Regenerative Medicine , by Region USD Million (2021-2026)
  • Table 153. Scaffold Technology Tissue Engineering , by Region USD Million (2021-2026)
  • Table 154. Scaffold Technology Microfluidics , by Region USD Million (2021-2026)
  • Table 155. Scaffold Technology Cell-based assays , by Region USD Million (2021-2026)
  • Table 156. Scaffold Technology Others , by Region USD Million (2021-2026)
  • Table 157. Scaffold Technology: by End users(USD Million)
  • Table 158. Scaffold Technology Cell attachment and migration , by Region USD Million (2021-2026)
  • Table 159. Scaffold Technology Nutrients and products diffusion , by Region USD Million (2021-2026)
  • Table 160. Scaffold Technology Cell phase behavior modification , by Region USD Million (2021-2026)
  • Table 161. Scaffold Technology Others , by Region USD Million (2021-2026)
  • Table 162. Scaffold Technology: by Technology(USD Million)
  • Table 163. Scaffold Technology Decellularized technology , by Region USD Million (2021-2026)
  • Table 164. Scaffold Technology Synthetic Scaffold , by Region USD Million (2021-2026)
  • Table 165. Scaffold Technology 3D printing , by Region USD Million (2021-2026)
  • Table 166. Scaffold Technology Others , by Region USD Million (2021-2026)
  • Table 167. South America Scaffold Technology, by Country USD Million (2021-2026)
  • Table 168. South America Scaffold Technology, by Type USD Million (2021-2026)
  • Table 169. South America Scaffold Technology, by Application USD Million (2021-2026)
  • Table 170. South America Scaffold Technology, by End users USD Million (2021-2026)
  • Table 171. South America Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 172. Brazil Scaffold Technology, by Type USD Million (2021-2026)
  • Table 173. Brazil Scaffold Technology, by Application USD Million (2021-2026)
  • Table 174. Brazil Scaffold Technology, by End users USD Million (2021-2026)
  • Table 175. Brazil Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 176. Argentina Scaffold Technology, by Type USD Million (2021-2026)
  • Table 177. Argentina Scaffold Technology, by Application USD Million (2021-2026)
  • Table 178. Argentina Scaffold Technology, by End users USD Million (2021-2026)
  • Table 179. Argentina Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 180. Rest of South America Scaffold Technology, by Type USD Million (2021-2026)
  • Table 181. Rest of South America Scaffold Technology, by Application USD Million (2021-2026)
  • Table 182. Rest of South America Scaffold Technology, by End users USD Million (2021-2026)
  • Table 183. Rest of South America Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 184. Asia Pacific Scaffold Technology, by Country USD Million (2021-2026)
  • Table 185. Asia Pacific Scaffold Technology, by Type USD Million (2021-2026)
  • Table 186. Asia Pacific Scaffold Technology, by Application USD Million (2021-2026)
  • Table 187. Asia Pacific Scaffold Technology, by End users USD Million (2021-2026)
  • Table 188. Asia Pacific Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 189. China Scaffold Technology, by Type USD Million (2021-2026)
  • Table 190. China Scaffold Technology, by Application USD Million (2021-2026)
  • Table 191. China Scaffold Technology, by End users USD Million (2021-2026)
  • Table 192. China Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 193. Japan Scaffold Technology, by Type USD Million (2021-2026)
  • Table 194. Japan Scaffold Technology, by Application USD Million (2021-2026)
  • Table 195. Japan Scaffold Technology, by End users USD Million (2021-2026)
  • Table 196. Japan Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 197. India Scaffold Technology, by Type USD Million (2021-2026)
  • Table 198. India Scaffold Technology, by Application USD Million (2021-2026)
  • Table 199. India Scaffold Technology, by End users USD Million (2021-2026)
  • Table 200. India Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 201. South Korea Scaffold Technology, by Type USD Million (2021-2026)
  • Table 202. South Korea Scaffold Technology, by Application USD Million (2021-2026)
  • Table 203. South Korea Scaffold Technology, by End users USD Million (2021-2026)
  • Table 204. South Korea Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 205. Taiwan Scaffold Technology, by Type USD Million (2021-2026)
  • Table 206. Taiwan Scaffold Technology, by Application USD Million (2021-2026)
  • Table 207. Taiwan Scaffold Technology, by End users USD Million (2021-2026)
  • Table 208. Taiwan Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 209. Australia Scaffold Technology, by Type USD Million (2021-2026)
  • Table 210. Australia Scaffold Technology, by Application USD Million (2021-2026)
  • Table 211. Australia Scaffold Technology, by End users USD Million (2021-2026)
  • Table 212. Australia Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Scaffold Technology, by Type USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Scaffold Technology, by Application USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Scaffold Technology, by End users USD Million (2021-2026)
  • Table 216. Rest of Asia-Pacific Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 217. Europe Scaffold Technology, by Country USD Million (2021-2026)
  • Table 218. Europe Scaffold Technology, by Type USD Million (2021-2026)
  • Table 219. Europe Scaffold Technology, by Application USD Million (2021-2026)
  • Table 220. Europe Scaffold Technology, by End users USD Million (2021-2026)
  • Table 221. Europe Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 222. Germany Scaffold Technology, by Type USD Million (2021-2026)
  • Table 223. Germany Scaffold Technology, by Application USD Million (2021-2026)
  • Table 224. Germany Scaffold Technology, by End users USD Million (2021-2026)
  • Table 225. Germany Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 226. France Scaffold Technology, by Type USD Million (2021-2026)
  • Table 227. France Scaffold Technology, by Application USD Million (2021-2026)
  • Table 228. France Scaffold Technology, by End users USD Million (2021-2026)
  • Table 229. France Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 230. Italy Scaffold Technology, by Type USD Million (2021-2026)
  • Table 231. Italy Scaffold Technology, by Application USD Million (2021-2026)
  • Table 232. Italy Scaffold Technology, by End users USD Million (2021-2026)
  • Table 233. Italy Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 234. United Kingdom Scaffold Technology, by Type USD Million (2021-2026)
  • Table 235. United Kingdom Scaffold Technology, by Application USD Million (2021-2026)
  • Table 236. United Kingdom Scaffold Technology, by End users USD Million (2021-2026)
  • Table 237. United Kingdom Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 238. Netherlands Scaffold Technology, by Type USD Million (2021-2026)
  • Table 239. Netherlands Scaffold Technology, by Application USD Million (2021-2026)
  • Table 240. Netherlands Scaffold Technology, by End users USD Million (2021-2026)
  • Table 241. Netherlands Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 242. Rest of Europe Scaffold Technology, by Type USD Million (2021-2026)
  • Table 243. Rest of Europe Scaffold Technology, by Application USD Million (2021-2026)
  • Table 244. Rest of Europe Scaffold Technology, by End users USD Million (2021-2026)
  • Table 245. Rest of Europe Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 246. MEA Scaffold Technology, by Country USD Million (2021-2026)
  • Table 247. MEA Scaffold Technology, by Type USD Million (2021-2026)
  • Table 248. MEA Scaffold Technology, by Application USD Million (2021-2026)
  • Table 249. MEA Scaffold Technology, by End users USD Million (2021-2026)
  • Table 250. MEA Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 251. Middle East Scaffold Technology, by Type USD Million (2021-2026)
  • Table 252. Middle East Scaffold Technology, by Application USD Million (2021-2026)
  • Table 253. Middle East Scaffold Technology, by End users USD Million (2021-2026)
  • Table 254. Middle East Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 255. Africa Scaffold Technology, by Type USD Million (2021-2026)
  • Table 256. Africa Scaffold Technology, by Application USD Million (2021-2026)
  • Table 257. Africa Scaffold Technology, by End users USD Million (2021-2026)
  • Table 258. Africa Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 259. North America Scaffold Technology, by Country USD Million (2021-2026)
  • Table 260. North America Scaffold Technology, by Type USD Million (2021-2026)
  • Table 261. North America Scaffold Technology, by Application USD Million (2021-2026)
  • Table 262. North America Scaffold Technology, by End users USD Million (2021-2026)
  • Table 263. North America Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 264. United States Scaffold Technology, by Type USD Million (2021-2026)
  • Table 265. United States Scaffold Technology, by Application USD Million (2021-2026)
  • Table 266. United States Scaffold Technology, by End users USD Million (2021-2026)
  • Table 267. United States Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 268. Canada Scaffold Technology, by Type USD Million (2021-2026)
  • Table 269. Canada Scaffold Technology, by Application USD Million (2021-2026)
  • Table 270. Canada Scaffold Technology, by End users USD Million (2021-2026)
  • Table 271. Canada Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 272. Mexico Scaffold Technology, by Type USD Million (2021-2026)
  • Table 273. Mexico Scaffold Technology, by Application USD Million (2021-2026)
  • Table 274. Mexico Scaffold Technology, by End users USD Million (2021-2026)
  • Table 275. Mexico Scaffold Technology, by Technology USD Million (2021-2026)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Scaffold Technology: by Type USD Million (2015-2020)
  • Figure 5. Global Scaffold Technology: by Application USD Million (2015-2020)
  • Figure 6. Global Scaffold Technology: by End users USD Million (2015-2020)
  • Figure 7. Global Scaffold Technology: by Technology USD Million (2015-2020)
  • Figure 8. South America Scaffold Technology Share (%), by Country
  • Figure 9. Asia Pacific Scaffold Technology Share (%), by Country
  • Figure 10. Europe Scaffold Technology Share (%), by Country
  • Figure 11. MEA Scaffold Technology Share (%), by Country
  • Figure 12. North America Scaffold Technology Share (%), by Country
  • Figure 13. Global Scaffold Technology share by Players 2020 (%)
  • Figure 14. Global Scaffold Technology share by Players (Top 3) 2020(%)
  • Figure 15. Global Scaffold Technology share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Koninklijke DSM N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 18. Koninklijke DSM N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 19. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Arterial Remodeling Technologies S.A (France) Revenue, Net Income and Gross profit
  • Figure 22. Arterial Remodeling Technologies S.A (France) Revenue: by Geography 2020
  • Figure 23. Spine Smith, LP (United States) Revenue, Net Income and Gross profit
  • Figure 24. Spine Smith, LP (United States) Revenue: by Geography 2020
  • Figure 25. Orthocell Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 26. Orthocell Ltd. (Australia) Revenue: by Geography 2020
  • Figure 27. Invivo Therapeutics Holdings Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Invivo Therapeutics Holdings Corporation (United States) Revenue: by Geography 2020
  • Figure 29. Lifenet Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Lifenet Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Biostage, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Biostage, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Arsenal Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Arsenal Medical Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Organogenesis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Organogenesis, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Tissue Regenix Group Plc. ((United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Tissue Regenix Group Plc. ((United Kingdom) Revenue: by Geography 2020
  • Figure 39. Global Scaffold Technology: by Type USD Million (2021-2026)
  • Figure 40. Global Scaffold Technology: by Application USD Million (2021-2026)
  • Figure 41. Global Scaffold Technology: by End users USD Million (2021-2026)
  • Figure 42. Global Scaffold Technology: by Technology USD Million (2021-2026)
  • Figure 43. South America Scaffold Technology Share (%), by Country
  • Figure 44. Asia Pacific Scaffold Technology Share (%), by Country
  • Figure 45. Europe Scaffold Technology Share (%), by Country
  • Figure 46. MEA Scaffold Technology Share (%), by Country
  • Figure 47. North America Scaffold Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Koninklijke DSM N.V. (Netherlands)
  • Thermo Fisher Scientific, Inc. (United States)
  • Arterial Remodeling Technologies S.A (France)
  • Spine Smith, LP (United States)
  • Orthocell Ltd. (Australia)
  • Invivo Therapeutics Holdings Corporation (United States)
  • Lifenet Inc. (United States)
  • Biostage, Inc. (United States)
  • Arsenal Medical Inc. (United States)
  • Organogenesis, Inc. (United States)
  • Tissue Regenix Group Plc. ((United Kingdom)
Additional players considered in the study are as follows:
3D Biotek LLC (United States) , Molecular Matrix, Inc. (United States) , ReproCELL Europe Ltd (Reinnervate) (United Kingdom) , Pelo Biotech GmbH (Germany)
Select User Access Type

Key Highlights of Report


Sep 2021 206 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Scaffold Technology market is expected to see a growth of % during projected year 2020 to 2026.
The prominent players of Global Scaffold Technology market are Koninklijke DSM N.V. (Netherlands), Thermo Fisher Scientific, Inc. (United States), Arterial Remodeling Technologies S.A (France), Spine Smith, LP (United States), Orthocell Ltd. (Australia), Invivo Therapeutics Holdings Corporation (United States), Lifenet Inc. (United States), Biostage, Inc. (United States), Arsenal Medical Inc. (United States), Organogenesis, Inc. (United States) and Tissue Regenix Group Plc. ((United Kingdom), to name a few.
In this highly competitive & fast evolving Scaffold Technology industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.

Know More About Global Scaffold Technology Market Report?